Sicong Zhu

TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma

Wenliang Tan, Xuan Luo, Wenda Li et al. · EBioMedicine · 2018 · 101 citations · Full text

GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma

Wenliang Tan, Kelin Zhang, Xinming Chen et al. · Journal of Advanced Research · 2022 · 49 citations · Full text

Inhibition of MMP-2 Expression Enhances the Antitumor Effect of Sorafenib in Hepatocellular Carcinoma by Suppressing the PI3K/AKT/mTOR Pathway

Wenliang Tan, Sicong Zhu, Jun Cao et al. · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · 2017 · 30 citations · Full text

Immunology, Mmp-2 Expression, Pathology +16

miR-126-3p contributes to sorafenib resistance in hepatocellular carcinoma via downregulating SPRED1

Wenliang Tan, Zhirong Lin, Xianqing Chen et al. · Annals of Translational Medicine · 2021 · 25 citations · Full text

miR-1226-3p Promotes Sorafenib Sensitivity of Hepatocellular Carcinoma via Downregulation of DUSP4 Expression

Xianqing Chen, Wenliang Tan, Wenxin Li et al. · Journal of Cancer · 2019 · 23 citations · Full text